Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (11): 1129-1135.doi: 10.3736/jcim20081106

• Original Clinical Research • Previous Articles     Next Articles

Effects of Xuefu Zhuyu Oral Liquid on hemorheology in patients with blood-stasis syndrome due to coronary disease and their relationship with human platelet antigen-3 polymorphism

Mei Xue, Ke-Ji Chen, Xiao-juan Ma, Jian-gang Liu, Yue-rong Jiang, Yu Miao, Hui-jun Yin()   

  1. Laboratory of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
  • Received:2008-06-18 Online:2008-11-20 Published:2008-11-15


To investigate the effects of Xuefu Zhuyu Oral Liquid, a compound traditional Chinese herbal medicine for resolving stagnation, on hemorheology in the patients with blood-stasis syndrome due to coronary disease and their relationship with human platelet antigen-3 (HPA-3) polymorphism of membrane glycoprotein Ⅱb (GPⅡb).


Thirty-two patients with blood-stasis syndrome due to coronary disease were selected in this study. Blood-stasis syndrome scoring was performed and hemorheological parameters were measured in all subjects before and after Xuefu Zhuyu Qral Liquid treatment. The genotypes of GPⅡb HPA-3 were determined by TaqMan probe technology.


The hemorheology was improved in the patients with blood-stasis syndrome due to coronary heart disease after the treatment. There were significant differences in the whole blood viscosity, deformation index of red blood cells and scores of blood-stasis syndrome between the patients carrying AC plus CC and the patients carrying AA after the treatment (P<0.05).


Xuefu Zhuyu Oral Liquid can improve clinical symptoms and hemorheology in the patients with blood-stasis syndrome due to coronary heart disease, which is related to GPⅡb HPA-3 polymorphism.

Key words: Xuefu Zhuyu Oral Liquid, coronary heart disease, blood stasis, hemorheology, platelet membrane glycoprotein H b, genes

CLC Number: 

  • R541.4

Table 1

GPⅡb HPA-3 (Baka/Bakb) polymorphism"

Amino acid pos HPA classification Personal name classification dbSNP allele dbSNP rs#cluster id
Ile 843 Ser

Table 2

GPⅡb PCR reaction system of primer detection"

Reaction component Concentration Volume (μl)
10×PCR buffer 10× 2.5
dNTP 2.5 pmol/μl 2.0
Forward primer 20 pmol/μl 0.5
Reverse primer 20 pmol/μl 0.5
Ex-Taq 0.125
H2O 18.375
Template 1.0
Total 25.0

Table 3

GPⅡb PCR reaction system of probe detection"

Reaction component Concentration Volume (μl)
2×TaqMan Master Mix 5.0
Forward primer 10 pmol/μl 0.45
Reverse primer 10 pmol/μl 0.45
TaqMan FAM probe 10 pmol/μl 0.25
TaqMan TET probe 10 pmol/μl 0.25
Template DNA 10 ng/μl 2.0
ddH2O 1.6
Total 10.0

Figure 1

Rs5911 genotype pattern Abscissa: TET signal intensity; Ordinate: FAM signal intensity; NTC: No template control; Red spot: Allele C homozygote; Blue spot: Allele A homozygote; Green spot: Heterozygote."

Table 4

Whole blood viscosity on HPA-3 polymorphism locus before and after treatment (x±s, mPa·s)"

Group n 1.0 s-1 5.0s-1 10.0 s-1 35.0 s-1 120.0 s-1
Before treatment 8 17.06±1.93 14.42±2.29 10.53±1.65 6.32±1.02 4.86±0.49
After treatment 8 17.19±1.61 14.83±1.24 10.07±1.45 6.75±1.41 5.03±0.57
Before treatment 24 17.57±2.86 15.31±2.83 11.02±1.71 6.74±0.87 4.63±0.47
After treatment 24 15.82±2.46* 13.37±2.05* 10.01±1.42* 6.62±0.58 4.61±0.39

Table 5

Hemorheology on HPA-3 polymorphism locus before and after treatment (x±s)"

Group n RBC concentration
RBC rigidity 1 500 s-1
Plasma viscosity
Maximum platelet
aggregation rate (%)
Platelet adhesion
rate (%)
Fibrinogen (g/L)
Before treatment 8 18.96±8.68 59.48±7.54 45.00±1.41 1.72±0.07 60.11±15.73 28.27±3.18 3.30±0.51
After treatment 8 17.00±5.91 60.54±6.85 44.63±1.09 1.72±0.06 57.61±13.00 28.08±5.85 3.27±0.46
Before treatment 24 14.09±4.36 63.25±3.58 44.19±1.71 1.73±0.04 58.03±14.88 27.90±3.06 3.16±0.36
After treatment 24 14.57±3.92 64.94±1.82* 43.40±2.11 1.72±0.04 57.47±12.03 28.90±2.89 3.14±0.33

Table 6

Scores of blood-stasis syndrome on HPA-3 polymorphism locus before and after treatment"

Group n Score of blood-stasis syndrome (x±s) P
Before treatment 8 25.88±7.57 0.058
After treatment 8 20.88±6.17
Before treatment 24 26.33±6.67 0.000
After treatment 24 19.04±6.76
[1] Di Castelnuovo A, de Gaetano G, Donati MB . Platelet glycoprotein GPⅡb-Ⅲa polymorphism and coronary artery disease: implications for clinical practice[J]. Am J Pharmacogenomics, 2005,5(2):93-99
doi: 10.2165/00129785-200505020-00002 pmid: 15813672
[2] Lagercrantz J, Bergman M, Lundman P , et al. No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein Ⅲa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction[J]. Blood Coagul Fibrinolysis, 2003,14(8):749-753
doi: 10.1097/00001721-200312000-00010
[3] Abu-Amero KK, Wyngaard CA, Dzimiri N . Association of the platelet glycoprotein receptor Ⅲa(PLA1/PLA1) genotype with coronary artery disease in Arabs[J]. Blood Coagul Fibrinolysis, 2004,15(1):77-79
doi: 10.1097/00001721-200401000-00012
[4] Pegoraro RJ, Ranjith N . Plasminogen activator inhibitor type 1(PAI-1) and platelet glycoprotein Ⅲa(PGⅢa) polymorphisms in young Asian Indians with acute myocardial infarction[J]. Cardiovasc J S Afr, 2005,16(5):266-270
[5] Papp E, Havasi V, Bene J , et al. Glycoprotein Ⅲa gene(PlA) polymorphism and aspirin resistance: is there any correlation?[J]. Ann Pharmacother, 2005,39(6):1013-1018
doi: 10.1345/aph.1E227
[6] Jackson SP, Schoenwaelder SM . Antiplatelet therapy: in search of the 'magic bullet'[J]. Nat Rev Drug Discov, 2003,2(10):775-789
doi: 10.1038/nrd1198 pmid: 14526381
[7] Chen HZ. Practical internal medicine(12th ed)[M]. Beijing: People's Medical Publishing House, 2005,( 12th ed):1472-1473
陈灏珠 . 实用内科学(第12版)[M]. 北京: 人民卫生出版社, 2005,( 第12版):1472-1473
[8] Chinese Association of Integrative Medicine, Professional Committee of Cardiology. The standard of syndrome differentiation for coronary heart disease[J]. Zhong Xi Yi Jie He Za Zhi, 1991,11(5):257
中国中西医结合学会心血管专业委员会. 冠心病中医辨证标准[J]. 中西医结合杂志, 1991,11(5):257
[9] Chinese Association of Integrative Medicine, Professional Committee of Promoting Blood Circulation and Removing Blood-stasis. Diagnostic criteria of blood-stasis syndrome[J]. Zhong Xi Yi Jie He Za Zhi, 1987,7(3):129
中国中西医结合学会活血化瘀专业委员会. 血瘀证诊断标准[J]. 中西医结合杂志, 1987,7(3):129
[10] Wang J. Study on diagnostic criteria of blood-stasis syndrome[M]. Beijing: United Publishing House of Beijing Medical University and Chinese Union Medical University,1993: 7
王阶 . 血瘀证诊断标准的研究[M]. 北京: 北京医科大学中国协和医科大学联合出版社,1993: 7
[11] Grove EL, rntoft TF, Lassen JF , et al. The platelet polymorphism PLA2 is a genetic risk factor for myocardial infarction[J]. J Intern Med, 2004,255(6):637-644
doi: 10.1111/jim.2004.255.issue-6
[12] Gochakova O, Koch W, Mehilli J , et al. PLA polymorphism of the glycoprotein Ⅲa and efficacy of reperfusion therapy in patients with acute myocardial infarction[J]. Thromb Haemost, 2004,91(1):141-145
[13] Cheng YB, Luo R, Xue YM , et al. Research of the association of the ACE gene with the kidney-asthenia type of DN[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi, 2002,8(5):29-33
doi: 10.3969/j.issn.1006-3250.2002.05.012
成玉斌, 罗仁, 薛耀明 , 等. 肾虚型DN与ACE基因多态性相关研究[J]. 中国中医基础医学杂志, 2002,8(5):29-33
doi: 10.3969/j.issn.1006-3250.2002.05.012
[14] You JS, Hu SY, Zhang HG . Study on emotion measurement of liver syndromes in TCM and its correlative study on polymorphism of serotonin(5-HT) transporter gene[J]. Zhongguo Yi Yao Xue Bao, 2004,19(11):669-671
doi: 10.3969/j.issn.1673-1727.2004.11.009
尤劲松, 胡随瑜, 张宏耕 . 中医肝证情绪测量及与5-羟色胺转运体基因多态性相关的研究[J]. 中国医药学报, 2004,19(11):669-671
doi: 10.3969/j.issn.1673-1727.2004.11.009
[15] Yang B, Hu JY, Hong MF , et al. Study on relationship between Arg778Leu/Gln gene mutation spot in ATP 7B and TCM syndrome type in Chinese patients with Wilson disease[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2002,22(4):280-282
doi: 10.7661/CJIM.2002.4.280
杨斌, 胡纪源, 洪铭范 , 等. 中国人Wilson病ATP7B基因Arg778Leu/Gln点突变与中医证型的相关性研究[J]. 中国中西医结合杂志, 2002,22(4):280-282
doi: 10.7661/CJIM.2002.4.280
[16] Mao YL, Yuan ZK, Huang XP , et al. Study on relationship between the polymorphism of angiotensin converting enzyme gene and blood stasis syndrome in patients with coronary heart disease[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2004,24(9):776-780
doi: 10.7661/CJIM.2004.9.776
毛以林, 袁肇凯, 黄献平 , 等. 冠心病血瘀证与血管紧张素转换酶基因多态性的相关性研究[J]. 中国中西医结合杂志, 2004,24(9):776-780
doi: 10.7661/CJIM.2004.9.776
[17] Ouyang T, Song JN, Miao Y , et al. Study on relationship between polymorphism of apolipoprotein E gene and syndromes of phlegm and blood stasis in patients with coronary heart disease[J]. Zhong Xi Yi Jie He Xue Bao, 2005,3(6):438-442
欧阳涛, 宋剑南, 苗阳 , 等. 冠心病痰瘀证与载脂蛋白E基因多态性关系的研究[J]. 中西医结合学报, 2005,3(6):438-442
[18] Li J, Yuan ZK, Huang XP , et al. The insertion/deletion polymorphism of angiotensin-converting enzyme gene and blood stasis syndrome in Han nation population with coronary heart disease[J]. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi, 2007,5(9):787-789
doi: 10.3969/j.issn.1672-1349.2007.09.002
李杰, 袁肇凯, 黄献平 , 等. 湖南汉族人群ACEI/D基因多态性与冠心病血瘀证的遗传流行病学研究[J]. 中西医结合心脑血管病杂志, 2007,5(9):787-789
doi: 10.3969/j.issn.1672-1349.2007.09.002
[19] Chen KJ, Shi ZX. Practical workbook of blood-stasis sydrome[M]. Beijing: People's Medical Publishing House,1999: 32
陈可冀, 史载祥 . 实用血瘀证学[M]. 北京: 人民卫生出版社,1999: 32
[1] Bhesh Raj Sharma, Dong Wook Kim, Dong Young Rhyu. Korean Chungtaejeon tea extract attenuates weight gain in C57BL/6J-Lep ob/ob mice and regulates adipogenesis and lipolysis in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2017, 15(1): 56-63.
[2] Santu Kumar Saha, Sourav Roy, Anisur Rahman Khuda-Bukhsh. Ultra-highly diluted plant extracts of Hydrastis canadensis and Marsdenia condurango induce epigenetic modifications and alter gene expression profiles in HeLa cells in vitro. Journal of Integrative Medicine, 2015, 13(6): 400-411.
[3] Oluwatosin Adaramoye, Bettina Erguen, Olubukola Oyebode, Bianca Nitzsche, Michael Höpfner, Klaus Jung, Anja Rabien. Antioxidant, antiangiogenic and antiproliferative activities of root methanol extract of Calliandra portoricensis in human prostate cancer cells. Journal of Integrative Medicine, 2015, 13(3): 185-193.
[4] Yuan-hui Zhang, Yuan Wang, Yusufali Ali Hussein, Frederick Ashby, Daniel Zhang, Zi-fei Yin, George V. Aslanidi, Arun Srivastava, Chang-quan Ling, Chen Ling. Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo. Journal of Integrative Medicine, 2014, 12(6): 483-494.
[5] Chang-quan Ling​, Xiao-qiang Yue, Chen Ling​. Three advantages of using traditional Chinese medicine to prevent and treat tumor. Journal of Integrative Medicine, 2014, 12(4): 331-335.
[6] Qian Zhang, Xin-hua Xiao, Ming Li, Wen-hui Li, Miao Yu, Hua-bing Zhang, Fan Ping, Zhi-xin Wang, Jia Zheng ​. Chromium-containing traditional Chinese medicine, Tianmai Xiaoke Tablet improves blood glucose through activating insulin-signaling pathway and inhibiting PTP1B and PCK2 in diabetic rats. Journal of Integrative Medicine, 2014, 12(3): 162-170.
[7] Ling Xu, Qiao-ling Zhou, Jie Han, Dan-ying Zhang, Hui-juan Dong, Zai-long Cai, Chao-qin Yu, Dong-xia Zhai . Effects of Chinese herbal medicine Neiyi Recipe-medicated serum on angiopoiesis of endometriosis in the chick chorioallantoic membrane model. Journal of Chinese Integrative Medicine, 2012, 10(7): 800-806.
[8] Ze-long Dai, Hui Chen, Xiao-ying Wu . Relationship between cytochrome P450 2C19*17 genotype distribution platelet aggregation and bleeding risk in patients with blood stasis syndrome of coronary artery disease treated with clopidogrel. Journal of Chinese Integrative Medicine, 2012, 10(6): 647-654.
[9] Chun Li, Yong Wang, Yu-lin Ouyang , Wen-jing Chuo , Qi Qiu , Shu-zhen Guo, Wei Wang. Effects of a compound Chinese herbal medicine Yixin Jiedu Formula on haemodynamic in rats with heart failure of qi-deficiency and blood stasis syndrome. Journal of Chinese Integrative Medicine, 2012, 10(5): 577-583.
[10] Gang Guo, Jian-hua Xu, Jian-hong Han, Fang Liang, Yong Zhang, Qiang Zhang, Jue Sun, Zhong-ze Fan . Chinese herbal decoction Shiquan Dabu Tang inhibits tumor growth and angiogenesis of metastasis after primary tumor surgical removal in mice. Journal of Chinese Integrative Medicine, 2012, 10(4): 436-447.
[11] Jong-Min Kim, Kyung-Soon Kim, Yeon-Weol Lee, Chong-Kwan Cho, Hwa-Seung Yoo, Ji-Young Bang, Eung-Yoon Kim, In-Cheol Kang. Anti-angiogenic effects of water extract of a formula consisting of Pulsatilla koreana, Panax ginseng and Glycyrrhiza uralensis. Journal of Chinese Integrative Medicine, 2011, 9(9): 1005-1013.
[12] Sui Yue Hu, Su E Wang, Chun Hu Zhang. Relationship between symptom stratification and syndrome differentiation of traditional Chinese medicine for depressive episode. Journal of Chinese Integrative Medicine, 2011, 9(9): 933-936.
[13] Liang-ping Hu, Xiao-lei Bao, Qi Wang . The repetition principle in scientific research. Journal of Chinese Integrative Medicine, 2011, 9(9): 937-940.
[14] Feng Jiang, Lin-chun Fu, Jian-ping Ma, Qing Zhou, Bo Peng, Shi-ping Xie, Hui-jun Guo, Yong-xin Dong, Xiu-lan Ma, Xuan-xian Guo, Zhong-li Xie, Yan-ping Hu, Qing-ya Li, Hua-wei Li, Yan-tao Jin. Traditional Chinese medicine syndrome factors of patients with HIV infection or AIDS in China. Journal of Chinese Integrative Medicine, 2011, 9(9): 955-964.
[15] Jin-xing Du, Ping Liu, Ming-yu Sun, Qing Tao, Li-jun Zhang, Gao-feng Chen, Yi-yang Hu, Cheng-hai Liu, Lie-ming Xu. Chinese herbal medicine Xiayuxue Decoction inhibits liver angiogenesis in rats with carbon tetrachloride-induced liver fibrosis. Journal of Chinese Integrative Medicine, 2011, 9(8): 878-887.
Full text



[1] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[2] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[5] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[6] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[7] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[8] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[9] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[10] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76